EP. 1: First-Line Therapy in Metastatic Pancreatic Cancer
EP. 2: Second-Line And Maintenance Therapy in Metastatic Pancreatic Cancer
EP. 3: Ongoing Research in Metastatic Pancreatic Cancer
Experts Weigh in on Topic of Frontline Osimertinib Alone or With Chemo in EGFR-Mutant NSCLC
Dr Sands on the Evolving Role of ADCs in SCLC Management
Dr Hirsch on the Treatment of NRG1 Fusion+ NSCLC
MRD Testing Requires Prospective Data to Assess Clinical Utility in Breast Cancer